Chromatographic method for the simultaneous quantification of dapsone and clofazimine in nanoformulations

• Tipo: Artigo em Revista Científica Internacional
• Data: 2018

Autores

Machado, S (Autor) Outra; Fernandes, SR (Autor) Outra; Chaves, LL (Autor) Outra; Lima, SAC (Autor) Outra; Silva, EMP (Autor) Outra; Barreiros, L (Autor) Outra; Salette Reis (Autor) FFUP; Marcela A Segundo (Autor) FFUP

Revista

Título: Journal of Separation Science

Vol. 41

Páginas: 3382-3388

ISSN: 1615-9306

Editora: Wiley-Blackwell

Indexação

ISI Web of Knowledge - 0 Citações

Scopus - 2 Citações

Outras Informações

ID Authenticus: P-00P-JNG

DOI: 10.1002/jssc.201800427

Abstract (EN): The low bioavailability and nonspecific distribution of dapsone and clofazimine, commonly applied in combination for the treatment of leprosy, can produce toxic effects. Nanotechnological approaches enhance the delivery of these drugs. Therefore, a high-performance liquid chromatography method was developed for the simultaneous determination of dapsone and clofazimine loaded in nanoformulations for quality control purposes. Chromatographic separation was achieved on a reversed-phase Kinetex core-shell C18 column, followed by spectrophotometric detection at 280nm. Considering the different physicochemical properties of dapsone and clofazimine, elution was performed in gradient mode using an aqueous acetate buffer (50mmol/L, pH 4.8) and an increasing acetonitrile content from 27 to 63% v/v at a flow rate of 1.0mL/min with retention times of 6.2 and 14.0min, respectively. The method was validated according to the European Medicines Agency guideline and it was found to be specific, accurate (99.6-114.0%), and precise for intra- (RSD1.8%) and interday assays (RSD12.5%). Both drugs showed stability after 24h at room temperature and over three freeze-thaw cycles with recoveries 86.2%. Low temperature (4 degrees C) in the autosampler caused the precipitation of clofazimine and must be avoided. The validated method was successfully applied in the quantification of both drugs in nanoformulations.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 8